Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
Stat Methods Med Res. 2023 Aug;32(8):1543-1558. doi: 10.1177/09622802231181220. Epub 2023 Jun 20.
In clinical research, it is important to study whether certain clinical factors or exposures have causal effects on clinical and patient-reported outcomes such as toxicities, quality of life, and self-reported symptoms, which can help improve patient care. Usually, such outcomes are recorded as multiple variables with different distributions. Mendelian randomization (MR) is a commonly used technique for causal inference with the help of genetic instrumental variables to deal with observed and unobserved confounders. Nevertheless, the current methodology of MR for multiple outcomes only focuses on one outcome at a time, meaning that it does not consider the correlation structure of multiple outcomes, which may lead to a loss of statistical power. In situations with multiple outcomes of interest, especially when there are mixed correlated outcomes with different distributions, it is much more desirable to jointly analyze them with a multivariate approach. Some multivariate methods have been proposed to model mixed outcomes; however, they do not incorporate instrumental variables and cannot handle unmeasured confounders. To overcome the above challenges, we propose a two-stage multivariate Mendelian randomization method (MRMO) that can perform multivariate analysis of mixed outcomes using genetic instrumental variables. We demonstrate that our proposed MRMO algorithm can gain power over the existing univariate MR method through simulation studies and a clinical application on a randomized Phase III clinical trial study on colorectal cancer patients.
在临床研究中,研究某些临床因素或暴露是否对毒性、生活质量和自我报告症状等临床和患者报告的结局有因果影响非常重要,这有助于改善患者护理。通常,这些结局被记录为具有不同分布的多个变量。孟德尔随机化 (MR) 是一种常用的因果推理技术,借助遗传工具变量来处理观察到和未观察到的混杂因素。然而,目前用于多结局的 MR 方法一次仅关注一个结局,这意味着它没有考虑多个结局的相关结构,这可能导致统计功效的损失。在有多个感兴趣的结局的情况下,特别是当存在具有不同分布的混合相关结局时,使用多变量方法联合分析它们更为理想。已经提出了一些用于模拟混合结局的多变量方法;然而,它们没有纳入工具变量,也无法处理未测量的混杂因素。为了克服上述挑战,我们提出了一种两阶段多变量孟德尔随机化方法 (MRMO),该方法可以使用遗传工具变量对混合结局进行多变量分析。我们通过模拟研究和对结直肠癌患者的一项随机 III 期临床试验的临床应用证明,我们提出的 MRMO 算法可以比现有的单变量 MR 方法获得更高的功效。